This article contains data related to the research article entitled "Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: the KORA F4 study" (Then et al., 2016) [1] and describes the association of the aldosterone to renin ratio with midregional-pro atrial natriuretic peptide (MR-proANP) and midregional-pro adrenomedullin (MR-proADM) Plasma MR-proANP, MR-proADM, renin and aldosterone were measured. Linear regression models were used to assess the association between MR-proANP/MRproADM and aldosterone-renin-ratio.
Specifications Table

Subject area
Diabetes More specific subject area
Cardiovascular disease in diabetes
Type of data Tables  How data was acquired
Cohort study
Data format Analyzed Experimental factors
Plasma samples were obtained from 1261 participants of the population-based KORA F4 cohort after an overnight fast.
Experimental features
Plasma MR-proANP, MR-proADM, renin and aldosterone were measured. Linear regression models were used to assess the association between MR-proANP/MRproADM and aldosterone-renin-ratio.
Data source location
Cooperative Health Research in the Region of Augsburg, Southern Germany
Data accessibility
The data is with this article
Value of the data
The aldosterone to renin ratio was only associated with MR-proANP and MR-proADM in subjects without diabetes or prediabetes.
The current data may be helpful for the planning of further clinical and/or preclinical research aiming to work out the differences in vasoactive hormones in subjects with and without diabetes.
Vasoactive prohormones, including MR-proANP and MR-proADM, are interesting candidates for future research focusing on the pathophysiological links between diabetes and cardiovascular disease.
Data
Two Tables are presented showing the associations of vasoactive prohormones with the aldosterone to renin ratio (ARR) in subjects with and without diabetes type 2 or prediabetes in a population-based cohort. Table 1 displays the association of the ARR with MR-proANP and Table 2 shows the relation of ARR and MR-proADM.
Experimental design, materials and methods
Recruitment of study participants, laboratory measurements and statistical analyses are described in detail elsewhere [1] . Briefly, the population-based KORA (Cooperative Health Research in the Region of Augsburg, southern Germany) F4 cohort includes 3080 participants recruited between 2006 and 2008. From this cohort, a sample of 1596 subjects was randomly selected for plasma MR-proANP and MR-proADM measurements. All variables required for the currently described analyses were available in 1261 study participants. ARR was calculated by dividing plasma aldosterone levels (ng/l) by plasma renin levels (ng/l). 
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